Arrhythmia events had been reported in numerous randomized controlled trials (RCTs) involving GLP-1 RAs, especially in several large-scale cardiovascular outcome trials (CVOTs) [7–12]. The gene discussed is GLP1R; the disease is cardiac arrhythmia.